Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wheatley

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 19, 2025
Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer RadiotherapyZ Nabi, D Megias, P Diez, et al.
Functional & Integrative Genomics|June 21, 2007
Transcript abundance profiles reveal larger and more complex responses of grapevine to chilling compared to osmotic and salinity stressElizabeth A R Tattersall, Jérôme Grimplet, Laurent DeLuc, et al.
British Journal of Cancer|March 18, 2010
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancerR E Coleman, M C Winter, D Cameron, et al.
Journal of Experimental Botany|April 20, 2007
Proteomic analysis reveals differences between Vitis vinifera L. cv. Chardonnay and cv. Cabernet Sauvignon and their responses to water deficit and salinityDelphine Vincent, Ali Ergül, Marlene C Bohlman, et al.
Minerva Pediatrica|April 14, 2018
Efficacy of anthropometric measures for identifying cardiovascular disease risk in adolescents: review and meta-analysisMichael Lichtenauer, Sean D Wheatley, Marrissa Martyn-St James, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 30, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UKH M Earl, L Hiller, J Dunn, et al.
ESMO Open|June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trialA Llombart-Cussac, J M Pérez-García, M Bellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 19, 2025
Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer RadiotherapyZ Nabi, D Megias, P Diez, et al.
Functional & Integrative Genomics|June 21, 2007
Transcript abundance profiles reveal larger and more complex responses of grapevine to chilling compared to osmotic and salinity stressElizabeth A R Tattersall, Jérôme Grimplet, Laurent DeLuc, et al.
British Journal of Cancer|March 18, 2010
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancerR E Coleman, M C Winter, D Cameron, et al.
Journal of Experimental Botany|April 20, 2007
Proteomic analysis reveals differences between Vitis vinifera L. cv. Chardonnay and cv. Cabernet Sauvignon and their responses to water deficit and salinityDelphine Vincent, Ali Ergül, Marlene C Bohlman, et al.
Minerva Pediatrica|April 14, 2018
Efficacy of anthropometric measures for identifying cardiovascular disease risk in adolescents: review and meta-analysisMichael Lichtenauer, Sean D Wheatley, Marrissa Martyn-St James, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 30, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UKH M Earl, L Hiller, J Dunn, et al.
ESMO Open|June 18, 2025
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trialA Llombart-Cussac, J M Pérez-García, M Bellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
Pageof 14